Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription

Articles published in
Am J Clin Pathol
    June 2021
    How Do Pathologists in Academic Institutions Across the United States and Canada Evaluate Sentinel Lymph Nodes in Breast Cancer?
    Am J Clin Pathol. 2021 Jun 24. pii: 6308671. doi: 10.1093.
    >> Share

    May 2021
  2. MUGABE M, Ho KE, Ruhangaza D, Milner D, et al
    Use of the Xpert Breast Cancer STRAT4 for Biomarker Evaluation in Tissue Processed in a Developing Country.
    Am J Clin Pathol. 2021 May 29. pii: 6288023. doi: 10.1093.
    >> Share

    March 2021
  3. POLONIA A, Campelos S, Ribeiro A, Aymore I, et al
    Artificial Intelligence Improves the Accuracy in Histologic Classification of Breast Lesions.
    Am J Clin Pathol. 2021;155:527-536.
    >> Share

    October 2020
  4. VAN BOCKSTAL MR, Berliere M, Duhoux FP, Galant C, et al
    Interobserver Variability in Ductal Carcinoma In Situ of the Breast.
    Am J Clin Pathol. 2020;154:596-609.
    >> Share

    April 2020
  5. ZHANG H, Moisini I, Ajabnoor RM, Turner BM, et al
    Frequency, Clinicopathologic Characteristics, and Follow-up of HER2-Positive Nonpleomorphic Invasive Lobular Carcinoma of the Breast.
    Am J Clin Pathol. 2020;153:583-592.
    >> Share

    February 2020
  6. ALGHAMDI SA, Krishnamurthy K, Garces Narvaez SA, Algashaamy KJ, et al
    Low-Grade Ductal Carcinoma In Situ.
    Am J Clin Pathol. 2020;153:360-367.
    >> Share

    January 2020
  7. BULTE JP, Halilovic A, Burgers LJM, Diepenbroek CJM, et al
    Accelerated Tissue Processing With Minimal Formalin Fixation Time for 9-Gauge Vacuum-Assisted Breast Biopsy Specimens.
    Am J Clin Pathol. 2020;153:58-65.
    >> Share

    June 2019
  8. LIN L, Sirohi D, Coleman JF, Gulbahce HE, et al
    American Society of Clinical Oncology/College of American Pathologists 2018 Focused Update of Breast Cancer HER2 FISH Testing GuidelinesResults From a National Reference Laboratory.
    Am J Clin Pathol. 2019 Jun 7. pii: 5512208. doi: 10.1093.
    >> Share

    March 2019
  9. MULLER KE, Marotti JD, Tafe LJ
    Pathologic Features and Clinical Implications of Breast Cancer With HER2 Intratumoral Genetic Heterogeneity.
    Am J Clin Pathol. 2019 Mar 20. pii: 5398564. doi: 10.1093.
    >> Share

    January 2019
  10. SCHNEIDER F, Jin Y, Van Smaalen K, Gulbahce EH, et al
    The FDA-Approved Breast Cancer HER2 Evaluation Kit (HercepTest; Dako) May Miss Some HER2-Positive Breast Cancers.
    Am J Clin Pathol. 2019 Jan 21. pii: 5298369. doi: 10.1093.
    >> Share

    July 2018
  11. KHOURY T, Peng X, Yan L, Wang D, et al
    Tumor-Infiltrating Lymphocytes in Breast Cancer: Evaluating Interobserver Variability, Heterogeneity, and Fidelity of Scoring Core Biopsies.
    Am J Clin Pathol. 2018 Jul 25. pii: 5059056. doi: 10.1093.
    >> Share

    May 2018
  12. LANDMANN A, Farrugia DJ, Zhu L, Diego EJ, et al
    Low Estrogen Receptor (ER)-Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy: Is Response Similar to Typical ER-Positive or ER-Negative Disease?
    Am J Clin Pathol. 2018 May 8. pii: 4993844. doi: 10.1093.
    >> Share

    February 2018
  13. CLARK BZ, Farrugia DJ, Landmann A, Diego EJ, et al
    Prognostic Significance of Modified Residual Disease in Breast and Nodes (mRDBN) Algorithm After Neoadjuvant Chemotherapy for Breast Cancer.
    Am J Clin Pathol. 2018 Feb 22. pii: 4899077. doi: 10.1093.
    >> Share

  14. KHOURY T
    Delay to Formalin Fixation (Cold Ischemia Time) Effect on Breast Cancer Molecules.
    Am J Clin Pathol. 2018 Feb 19. pii: 4874188. doi: 10.1093.
    >> Share

    November 2017
  15. SHIN ET, Joehlin-Price AS, Agnese DM, Zynger DL, et al
    Minimal Clinical Impact of Intraoperative Examination of Sentinel Lymph Nodes in Patients With Ductal Carcinoma In Situ: An Opportunity for Improved Resource Utilization.
    Am J Clin Pathol. 2017;148:374-379.
    >> Share

    October 2017
    Impact of 2013 American Society of Clinical Oncology/College of American Pathologists Guidelines on HER2 Fluorescent In Situ Hybridization Testing in Breast Cancers : Experience From a National Reference Laboratory.
    Am J Clin Pathol. 2017;148:308-313.
    >> Share

    August 2017
  17. KHOURY T, Zirpoli G, Cohen SM, Geradts J, et al
    Ki-67 Expression in Breast Cancer Tissue Microarrays: Assessing Tumor Heterogeneity, Concordance With Full Section, and Scoring Methods.
    Am J Clin Pathol. 2017;148:108-118.
    >> Share

  18. HOU Y, Zynger DL, Li X, Li Z, et al
    Comparison of Oncotype DX With Modified Magee Equation Recurrence Scores in Low-Grade Invasive Carcinoma of Breast.
    Am J Clin Pathol. 2017;148:167-172.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016